MedTrace Logo

Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization

NCT01677702 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2012-10-25

No results posted yet for this study

Summary

The purpose of this study is to determine whether Yili Lactoferrin ShuHua Milk are effective in reducing the occurrence of flu symptoms.

Conditions

  • Immunization
  • Human Influenza
  • Common Cold

Interventions

DIETARY_SUPPLEMENT

Yili Lactoferrin ShuHua Milk (Lactoferrin 5mg/100ml)

Total 250mL milk (with lactoferrin 5mg/100ml) will be taken once per day at 10am daily during the 84 days intervention.

DIETARY_SUPPLEMENT

Yili Lactoferrin ShuHua Milk (Lactoferrin 10mg/100ml)

Total 250mL milk (with lactoferrin 10mg/100ml) will be taken once per day at 10am daily during the 84 days intervention.

DIETARY_SUPPLEMENT

Recombined low protein milk

Total 250ml of placebo milk will be taken once a day at 10am daily during the 84 day intervention.

Sponsors & Collaborators

  • Inner Mongolia Yili Industrial Group Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Ying An, Ph.D · Inner Mongolia Hilo Industrial Group Co., Ltd

  • Donglian Cai · Changhai Hospital of Shanghai, Nutriology Dept.

  • Yeqing Shi · Changhai Hospital of Shanghai, Rheumatology Dept.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-07-31
Completion
2011-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01677702 on ClinicalTrials.gov